GO:0001727 lipid kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001727 lipid kinase activity is a molecular function defined as the catalysis of phosphorylation of a simple or complex lipid.
• Lipid kinases transfer a phosphate group from ATP to lipid substrates, producing phosphorylated lipid products that act as signaling molecules or membrane anchors.
• Key lipid kinase families include phosphoinositide 3-kinases (PI3Ks), phosphatidylinositol 4-phosphate 5-kinases (PIP5Ks), sphingosine kinases (SPHKs), and pantothenate kinases (PANKs).
• Lipid kinase activity is critical for signal transduction, membrane trafficking, cell growth, and metabolic regulation.
• Dysregulated lipid kinase activity is implicated in cancer, metabolic disorders, and kidney injury.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise functional dissection of lipid kinase genes.
Description
Lipid kinase activity (GO:0001727) is a fundamental molecular function that governs the phosphorylation of lipid molecules, a process central to cellular signaling and membrane dynamics. This activity is carried out by a diverse group of enzymes that transfer the gamma-phosphate of ATP to lipid substrates, generating bioactive lipids such as phosphoinositides and sphingosine-1-phosphate. The importance of lipid kinases extends across all eukaryotic life, where they regulate processes ranging from vesicular trafficking to cell proliferation and survival. Researchers study lipid kinase activity to understand how cells interpret and respond to environmental cues, and how disruptions in these pathways contribute to human diseases including cancer, diabetes, and acute kidney injury. The development of sensitive detection methods, such as nanocatalyst-based assays, has further advanced the quantification of lipid kinase activity in biological samples. This article provides a comprehensive overview of the mechanisms, key genes, and research methodologies associated with GO:0001727, based on authoritative QuickGO data and verified PubMed literature.
lipid kinase activity At A Glance
| GO ID | GO:0001727 |
|---|---|
| GO term | lipid kinase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of the phosphorylation of a simple or complex lipid |
| EC number | 2.7.1.- (phosphotransferases with an alcohol group as acceptor) |
| Substrates | Various lipids including phosphatidylinositol, sphingosine, and pantothenate |
| Products | Phosphorylated lipids such as phosphatidylinositol phosphates and sphingosine-1-phosphate |
| Cofactors | ATP (or other nucleoside triphosphates) and divalent metal ions (e.g., Mg2+ or Mn2+) |
What Is GO:0001727?
According to the Gene Ontology, lipid kinase activity (GO:0001727) is defined as the catalysis of the phosphorylation of a simple or complex lipid. In other words, it is the enzymatic function by which a phosphate group is added to a lipid molecule, typically using ATP as the phosphate donor. This modification can alter the lipid's chemical properties, enabling it to serve as a signaling intermediate, a membrane docking site, or a precursor for other bioactive lipids.
Why Is lipid kinase activity Important in Cell Biology?
Lipid kinase activity is essential for a wide array of cellular processes, including signal transduction, membrane trafficking, and metabolic homeostasis. Dysregulation of lipid kinases is linked to numerous human diseases, such as cancer, where aberrant PI3K signaling drives tumor growth, and metabolic disorders, where pantothenate kinase 4 (PANK4) controls skeletal muscle substrate metabolism. Moreover, lipid kinases are emerging as therapeutic targets, and understanding their activity is crucial for drug discovery and for interpreting disease mechanisms.
• Lipid kinases generate second messengers like phosphatidylinositol (3,4,5)-trisphosphate (PIP3) that regulate cell survival and proliferation.
• They are key regulators of membrane identity and vesicular transport through local synthesis of phosphoinositides.
• Sphingosine kinase 1 (SPHK1) produces sphingosine-1-phosphate (S1P), which controls muscle adaptation to endurance exercise.
• Pantothenate kinase 4 (PANK4) modulates skeletal muscle substrate metabolism and exercise performance.
• PIP5Kα contributes to Hippo pathway activation by mediating plasma membrane targeting of LATS1.
• Lipid kinase activity is involved in the cellular response to exercise, including AMPK and mTOR signaling.
• Aberrant lipid kinase activity is implicated in cancer, neurodegeneration, and kidney injury.
• Detection of lipid kinase activity is important for clinical diagnostics and drug screening.
• CRISPR-based models allow precise manipulation of lipid kinase genes to study their functions.
• Lipid kinases are potential targets for therapies against metabolic and proliferative diseases.
Core Mechanisms of lipid kinase activity
Substrate Recognition and Binding
In simple terms: The enzyme first grabs the lipid it will modify.
Lipid kinases exhibit specificity for their lipid substrates, which can include phosphatidylinositol, sphingosine, or pantothenate. For example, phosphoinositide 3-kinase-C2beta (PI3K-C2β) binds to clathrin through its N-terminus, which regulates its lipid kinase activity and subcellular localization. Similarly, PIP5Kα interacts with Merlin to mediate plasma membrane targeting of LATS1, demonstrating that substrate recognition is coupled to protein-protein interactions. The binding of the lipid substrate occurs in a hydrophobic pocket that positions the hydroxyl group for phosphorylation.
Phosphoryl Transfer Reaction
In simple terms: The enzyme transfers a phosphate from ATP onto the lipid.
The catalytic mechanism involves the transfer of the gamma-phosphate of ATP to the hydroxyl group of the lipid substrate, forming a phosphoester bond. This reaction requires divalent metal ions such as Mg2+ or Mn2+ to neutralize the negative charges of ATP and stabilize the transition state. The reaction produces a phosphorylated lipid and ADP. For instance, sphingosine kinase 1 (SPHK1) phosphorylates sphingosine to generate sphingosine-1-phosphate (S1P), a bioactive lipid that regulates muscle adaptive responses to endurance exercise.
Product Release and Signaling
In simple terms: The modified lipid is released and can now send signals.
After phosphorylation, the lipid product is released from the enzyme and can interact with downstream effectors. Phosphatidylinositol phosphates, for example, recruit proteins with pleckstrin homology (PH) domains to membranes, thereby propagating signals. S1P can bind to S1P receptors (S1PR1/S1PR2) to activate intracellular pathways. The release of products is often coupled to changes in membrane curvature and charge, influencing protein recruitment and vesicle trafficking.
Regulation by Protein-Protein Interactions
In simple terms: Other proteins can turn the enzyme on or off or tell it where to go.
Lipid kinase activity is tightly regulated by interacting proteins and post-translational modifications. The N-terminus of PI3K-C2β regulates its lipid kinase activity and binding to clathrin, affecting its function in endocytosis. PIP5Kα interacts with Merlin, a tumor suppressor, to mediate plasma membrane targeting of LATS1 and activate the Hippo pathway. Additionally, lipid transfer proteins can present lipid substrates to kinases, thereby instructing their activity. These interactions ensure that lipid phosphorylation occurs at the right time and place.
Integration with Cellular Metabolism
In simple terms: Lipid kinases are part of the cell's energy and metabolic control.
Lipid kinase activity is integrated with cellular energy status and metabolism. Pantothenate kinase 4 (PANK4) controls skeletal muscle substrate metabolism, influencing fuel selection and exercise capacity. Exercise-mediated coordination of AMPK, mTOR, and NF-κB signaling involves lipid kinase-dependent pathways that protect against acute kidney injury. Thus, lipid kinases serve as metabolic sensors and effectors, linking lipid phosphorylation to whole-body physiology.
Key Genes Involved in GO:0001727 lipid kinase activity
The following table lists key genes encoding lipid kinases or related proteins, along with their major roles and research relevance, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIK3C2B | Phosphoinositide 3-kinase-C2beta; regulates lipid kinase activity and clathrin binding | Studied for endocytosis and signal transduction |
| PIP5K1A | Phosphatidylinositol 4-phosphate 5-kinase alpha; contributes to Hippo pathway via Merlin and LATS1 | Implicated in cancer and organ size control |
| SPHK1 | Sphingosine kinase 1; produces sphingosine-1-phosphate (S1P) | Role in muscle adaptation to endurance exercise |
| PANK4 | Pantothenate kinase 4; controls skeletal muscle substrate metabolism | Metabolic regulation and exercise performance |
| PANK1 | Pantothenate kinase 1; catalyzes phosphorylation of pantothenate | Coenzyme A biosynthesis and metabolic disorders |
| PANK2 | Pantothenate kinase 2; mitochondrial pantothenate kinase | Neurodegeneration with brain iron accumulation |
| PANK3 | Pantothenate kinase 3; cytosolic pantothenate kinase | Metabolic regulation |
| PIK3CA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha | Oncogenic mutations in cancer |
| PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta | Insulin signaling and metabolism |
| PIK3CD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta | Immune cell signaling |
| PIK3CG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma | Inflammation and immune response |
| PIP4K2A | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | Phosphoinositide signaling |
| PIP4K2B | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | Stress response and metabolism |
| SPHK2 | Sphingosine kinase 2; produces S1P | Apoptosis and cancer |
| DGKA | Diacylglycerol kinase alpha; phosphorylates diacylglycerol to phosphatidic acid | T cell signaling and cancer |
| DGKZ | Diacylglycerol kinase zeta; regulates diacylglycerol levels | Immune synapse and cancer |
| CERT1 | Ceramide transfer protein; regulates lipid kinase activities | Inositol lipid signaling and disease |
| PITPNB | Phosphatidylinositol transfer protein beta; presents lipids to kinases | Inositol lipid signaling |
How Is lipid kinase activity Regulated?
Lipid kinase activity is regulated at multiple levels, including protein-protein interactions, post-translational modifications, and metabolic cues. For instance, the N-terminus of PI3K-C2β regulates its lipid kinase activity and binding to clathrin, affecting its function in endocytosis. PIP5Kα interacts with Merlin to mediate plasma membrane targeting of LATS1, thereby activating the Hippo pathway. Lipid transfer proteins can instruct lipid kinase activities by presenting specific lipid substrates, as reviewed by Lete et al.. Additionally, exercise-mediated signaling through AMPK, mTOR, and NF-κB pathways coordinates lipid kinase-dependent responses in kidney protection. Pantothenate kinase 4 (PANK4) is regulated by metabolic status and controls skeletal muscle substrate metabolism. These regulatory mechanisms ensure that lipid phosphorylation is spatially and temporally controlled.
lipid kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIK3CA | Cancer (oncogenic mutations) | Knock-in of activating mutations in cell lines; xenograft models |
| PANK2 | Neurodegeneration with brain iron accumulation | Knockout or point-mutation knock-in in neurons; mouse models |
| SPHK1 | Muscle adaptation to exercise; cancer | Knockout mice; skeletal muscle-specific overexpression |
| PIP5K1A | Cancer; Hippo pathway dysregulation | Knockout and overexpression in cancer cell lines |
| PANK4 | Metabolic disorders; insulin resistance | Knockout mice; skeletal muscle-specific knockout |
Cancer
Dysregulated lipid kinase activity is a hallmark of many cancers. Oncogenic mutations in PIK3CA, which encodes the p110α catalytic subunit of PI3K, lead to constitutive lipid kinase activity and drive tumor growth. PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1, and its dysregulation may promote cancer. Sphingosine kinase 1 (SPHK1) produces S1P, which can promote cell survival and proliferation, and is implicated in cancer progression.
Metabolic Disorders
Lipid kinases play critical roles in metabolic regulation. Pantothenate kinase 4 (PANK4) controls skeletal muscle substrate metabolism, and its dysfunction may contribute to metabolic disorders such as insulin resistance. Exercise-mediated coordination of AMPK energy homeostasis, mTOR autophagy regulation, and NF-κB inflammatory control involves lipid kinase-dependent pathways that protect against acute kidney injury. These findings highlight the importance of lipid kinases in whole-body metabolism.
Neurodegeneration
Mutations in pantothenate kinase 2 (PANK2) cause neurodegeneration with brain iron accumulation (NBIA), a rare disorder characterized by iron accumulation in the brain. This underscores the critical role of lipid kinases in neuronal health. Additionally, lipid transfer proteins and instructive regulation of lipid kinase activities have implications for inositol lipid signaling and disease, including neurodegeneration.
Kidney Injury
Exercise-mediated coordination of AMPK energy homeostasis, mTOR autophagy regulation, and NF-κB inflammatory control involves lipid kinase activity and provides multi-target renal protection in acute kidney injury (AKI). This suggests that modulating lipid kinase pathways could be therapeutic in kidney diseases.
From lipid kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of lipid kinase X affect cell proliferation? | CRISPR knockout in cancer cell lines followed by proliferation assays |
| Does a specific point mutation in lipid kinase Y alter its activity? | CRISPR point mutation knock-in in isogenic cell lines |
| How does tagging lipid kinase Z affect its localization? | CRISPR knock-in of fluorescent or epitope tags |
| What is the effect of lipid kinase overexpression on signaling? | CRISPR activation or cDNA overexpression |
| Which genes regulate lipid kinase activity in a genome-wide screen? | CRISPR library screening with lipid kinase activity readout |
| How does lipid kinase activity change during exercise? | Knockout mouse models subjected to endurance exercise |
How to Study the lipid kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro kinase assay | Enzymatic activity of lipid kinases | Screening inhibitors; kinetic studies |
| CRISPR knockout | Loss-of-function phenotype | Determining gene essentiality |
| CRISPR point mutation knock-in | Effect of specific mutations | Modeling disease variants |
| RNA-seq | Transcriptional changes | Pathway analysis upon lipid kinase modulation |
| Phosphoproteomics | Phosphorylation events | Identifying downstream signaling |
| Fluorescence microscopy | Subcellular localization | Studying membrane targeting |
| CRISPR library screening | Genome-wide fitness or reporter readout | Identifying regulators of lipid kinase activity |
| Nanocatalyst-based assay | Sensitive detection of lipid kinase activity | Clinical diagnostics and drug discovery |
Biochemical Assays for Lipid Kinase Activity
Lipid kinase activity can be measured using in vitro kinase assays with purified enzymes or cell lysates, employing radioactive ATP or fluorescent lipid substrates. A nanocatalyst-based method has been developed for the determination of lipid kinase activity, offering high sensitivity. These assays are essential for screening inhibitors and studying enzyme kinetics.
Genetic Manipulation with CRISPR
CRISPR-Cas9 technology enables the generation of knockout, point mutation, knock-in, and overexpression models to study lipid kinase genes. For example, knockout of PIP5K1A has been used to investigate its role in Hippo pathway activation. Point mutations can be introduced to mimic disease-associated variants, such as those in PIK3CA. These models allow causal inference between lipid kinase activity and cellular phenotypes.
Omics Approaches
Transcriptomics (RNA-seq) and proteomics can reveal changes in gene expression and protein abundance upon modulation of lipid kinase activity. Phosphoproteomics can identify downstream signaling events. For instance, exercise-induced changes in muscle lipid kinase pathways have been studied using omics. These methods provide a global view of the cellular response to altered lipid phosphorylation.
Imaging and Localization Studies
Fluorescence microscopy with tagged lipid kinases or lipid biosensors can visualize the subcellular localization and dynamics of lipid kinase activity. The interaction of PI3K-C2β with clathrin was studied using imaging techniques. PIP5Kα plasma membrane targeting of LATS1 was also visualized by microscopy. These approaches are crucial for understanding spatial regulation.
How CRISPR Can Be Used to Study GO:0001727 lipid kinase activity
Knockout
CRISPR knockout of lipid kinase genes, such as PIP5K1A, has been used to demonstrate its role in Hippo pathway activation via Merlin and LATS1. Knockout models are invaluable for assessing loss-of-function phenotypes and validating drug targets. For example, PANK4 knockout mice exhibit altered skeletal muscle substrate metabolism.
Point Mutation
Point mutation knock-in via CRISPR allows the study of specific amino acid changes that affect lipid kinase activity. This is particularly relevant for oncogenic mutations in PIK3CA, where single-nucleotide variants lead to constitutive activity. Such models help dissect the contribution of individual mutations to disease.
Knock-in
Knock-in of tags or reporters into endogenous lipid kinase loci enables real-time tracking of protein localization and activity. For instance, tagging PI3K-C2β can reveal its interaction with clathrin. Knock-in of fluorescent proteins also facilitates live-cell imaging of lipid kinase dynamics.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can drive high levels of lipid kinase expression to study gain-of-function effects. Overexpression of SPHK1, for example, increases S1P production and affects muscle adaptation. Overexpression models are useful for identifying downstream signaling pathways and potential oncogenic roles.
How EDITGENE Supports lipid kinase activity Research
Researchers studying lipid kinase activity-related genes often need to determine whether a candidate gene is causally involved in a specific cellular process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation and functional interrogation of lipid kinase genes.
Contact EDITGENE today to design your custom CRISPR model for lipid kinase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SPHK1 Knockout HEK293 Cell Line | EDJ-KQ1066 | Human | 8877 | Details Get a Quote |
| SPHK2 Knockout HEK293 Cell Line | EDJ-KQ1413 | Human | 56848 | Details Get a Quote |
| PIK3C2B Knockout HEK293 Cell Line | EDJ-KQ1680 | Human | 5287 | Details Get a Quote |
| AGK Knockout HEK293 Cell Line | EDJ-KQ12308 | Human | 55750 | Details Get a Quote |
| CERKL Knockout HEK293 Cell Line | EDJ-KQ12875 | Human | 375298 | Details Get a Quote |
| DGKZ Knockout HEK293 Cell Line | EDJ-KQ17868 | Human | 8525 | Details Get a Quote |
| SPHK1 Knockout A-549 Cell Line | EDJ-KQ20196 | Human | 8877 | Details Get a Quote |
| SPHK1 Knockout HCT 116 Cell Line | EDJ-KQ20197 | Human | 8877 | Details Get a Quote |
| SPHK2 Knockout A-549 Cell Line | EDJ-KQ20951 | Human | 56848 | Details Get a Quote |
| SPHK2 Knockout HCT 116 Cell Line | EDJ-KQ20952 | Human | 56848 | Details Get a Quote |
| SPHK2 Knockout HeLa Cell Line | EDJ-KQ20953 | Human | 56848 | Details Get a Quote |
| AGK Knockout A-549 Cell Line | EDJ-KQ41139 | Human | 55750 | Details Get a Quote |
| AGK Knockout HCT 116 Cell Line | EDJ-KQ41140 | Human | 55750 | Details Get a Quote |
| AGK Knockout HeLa Cell Line | EDC90512 | Human | 55750 | Details Get a Quote |
| SPHK1 Knockout HeLa Cell Line | EDJ-KQ18852 | Human | 8877 | Details Get a Quote |
Displaying Records 1 To 15 Of 26 Records
Frequently Asked Questions About lipid kinase activity
What is lipid kinase activity?
Lipid kinase activity (GO:0001727) is the catalysis of the phosphorylation of a simple or complex lipid, typically using ATP as the phosphate donor.
What genes are involved in lipid kinase activity?
Key genes include PIK3C2B, PIP5K1A, SPHK1, PANK4, PIK3CA, and others encoding phosphoinositide, sphingosine, and pantothenate kinases.
What diseases are associated with lipid kinase activity?
Dysregulated lipid kinase activity is linked to cancer, metabolic disorders, neurodegeneration, and acute kidney injury.
How is lipid kinase activity measured?
It can be measured using in vitro kinase assays, including a nanocatalyst-based method for sensitive detection.
What is the role of PIP5Kα in the Hippo pathway?
PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
How does sphingosine kinase 1 affect exercise?
SPHK1 produces sphingosine-1-phosphate (S1P), which facilitates muscle adaptive responses to endurance exercise through S1PR1/S1PR2 in slow-twitch myofibers.
What is the function of pantothenate kinase 4?
PANK4 controls skeletal muscle substrate metabolism and influences exercise performance.
Can CRISPR be used to study lipid kinase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional dissection of lipid kinase genes.
What is the GO definition of lipid kinase activity?
The Gene Ontology defines it as catalysis of the phosphorylation of a simple or complex lipid.
How does lipid kinase activity relate to kidney injury?
Exercise-mediated coordination of AMPK, mTOR, and NF-κB pathways involves lipid kinase activity and provides multi-target renal protection in acute kidney injury.
Conclusion
Lipid kinase activity (GO:0001727) is a central molecular function that regulates diverse cellular processes through the phosphorylation of lipids. Its dysregulation contributes to cancer, metabolic disorders, neurodegeneration, and kidney injury, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and sensitive detection methods continue to unravel the complexities of lipid kinase biology. EDITGENE's comprehensive services empower researchers to dissect lipid kinase functions with precision and efficiency.
References
- 1. Gao T et al.. 2018. Embedding Capture-Magneto-Catalytic Activity into a Nanocatalyst for the Determination of Lipid Kinase.. ACS Appl Mater Interfaces 10(1):59-65 PMID: 29231711
- 2. Miranda-Cervantes A et al.. 2025. Pantothenate kinase 4 controls skeletal muscle substrate metabolism.. Nat Commun 16(1):345 PMID: 39746949
- 3. Leng M et al.. 2025. Mitophagy-mediated S1P facilitates muscle adaptive responses to endurance exercise through SPHK1-S1PR1/S1PR2 in slow-twitch myofibers.. Autophagy 21(10):2111-2129 PMID: 40181214
- 4. Wheeler M et al.. 2006. The N-terminus of phosphoinositide 3-kinase-C2beta regulates lipid kinase activity and binding to clathrin.. J Cell Physiol 206(3):586-93 PMID: 16222711
- 6. Lete MG et al.. 2020. Lipid transfer proteins and instructive regulation of lipid kinase activities: Implications for inositol lipid signaling and disease.. Adv Biol Regul 78:100740 PMID: 32992233
- 7. Le TPH et al.. 2023. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.. Cell Commun Signal 21(1):149 PMID: 37337213
- 8. Wang X et al.. 2025. Multi-target renal protection in AKI: Exercise-mediated coordination of AMPK energy homeostasis, mTOR autophagy regulation, and NF-κB inflammatory control.. Free Radic Biol Med 240:397-409 PMID: 40846098
